Artemis Medicare Services Ltd.(IN:ARTEMISMED)
₹343.35-5.55 (-1.59%)
IN:ARTEMISMED
Artemis Medicare Services Ltd. financials statements
₹343.35
At close:-5.55 (-1.59%)
Want to see IN:ARTEMISMED full AI Analyst Report?
Artemis Medicare Services Ltd. (ARTEMISMED) Ratios
2 Followers
Artemis Medicare Services Ltd. Ratios
IN:ARTEMISMED's free cash flow for Q2 2027 was ₹0.00. For the 2027 fiscal year, IN:ARTEMISMED's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.74 | 2.49 | 0.98 | 0.83 | 0.92 |
| Quick Ratio | 1.68 | 2.45 | 0.92 | 0.76 | 0.83 |
| Cash Ratio | 0.98 | 1.83 | 0.08 | 0.11 | 0.11 |
| Solvency Ratio | 0.31 | 0.25 | 0.16 | 0.14 | 0.16 |
| Operating Cash Flow Ratio | 0.65 | 0.67 | 0.59 | 0.55 | 0.37 |
| Short-Term Operating Cash Flow Coverage | 3.37 | 4.01 | 4.21 | 4.03 | 2.32 |
| Net Current Asset Value | ₹ -1.21B | ₹ 250.08M | ₹ -3.37B | ₹ -3.27B | ₹ -2.21B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.18 | 0.21 | 0.33 | 0.32 | 0.28 |
| Debt-to-Equity Ratio | 0.28 | 0.35 | 0.71 | 0.71 | 0.56 |
| Debt-to-Capital Ratio | 0.22 | 0.26 | 0.42 | 0.41 | 0.36 |
| Long-Term Debt-to-Capital Ratio | 0.17 | 0.20 | 0.34 | 0.35 | 0.31 |
| Financial Leverage Ratio | 1.53 | 1.62 | 2.17 | 2.24 | 1.97 |
| Debt Service Coverage Ratio | 2.23 | 1.85 | 1.84 | 1.86 | 1.91 |
| Interest Coverage Ratio | 5.06 | 6.99 | 5.13 | 3.29 | 3.79 |
| Debt to Market Cap | 0.07 | 0.06 | 0.11 | 0.27 | 0.30 |
| Interest Debt Per Share | 18.31 | 20.71 | 25.89 | 22.91 | 16.10 |
| Net Debt to EBITDA | 0.29 | -0.69 | 2.45 | 2.60 | 2.60 |
| Profitability Margins | |||||
| Gross Profit Margin | 19.93% | 23.84% | 20.21% | 14.07% | 17.27% |
| EBIT Margin | 12.96% | 11.38% | 10.64% | 9.54% | 8.89% |
| EBITDA Margin | 17.40% | 16.20% | 14.18% | 13.75% | 12.91% |
| Operating Profit Margin | 12.96% | 23.84% | 18.27% | 8.79% | 8.21% |
| Pretax Profit Margin | 12.87% | 11.49% | 7.79% | 6.87% | 6.73% |
| Net Profit Margin | 9.58% | 8.82% | 5.59% | 5.24% | 5.76% |
| Continuous Operations Profit Margin | 9.59% | 8.77% | 5.59% | 5.16% | 5.68% |
| Net Income Per EBT | 74.45% | 76.74% | 71.79% | 76.27% | 85.56% |
| EBT Per EBIT | 99.33% | 48.21% | 42.66% | 78.13% | 81.97% |
| Return on Assets (ROA) | 7.25% | 6.09% | 5.06% | 4.27% | 4.48% |
| Return on Equity (ROE) | 11.09% | 9.86% | 10.96% | 9.57% | 8.85% |
| Return on Capital Employed (ROCE) | 11.50% | 19.57% | 20.39% | 9.26% | 7.94% |
| Return on Invested Capital (ROIC) | 8.30% | 14.42% | 14.04% | 6.65% | 6.42% |
| Return on Tangible Assets | 7.54% | 6.33% | 5.32% | 4.51% | 4.79% |
| Earnings Yield | 3.19% | 1.96% | 2.07% | 4.26% | 5.24% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.62 | 9.25 | 8.66 | 7.25 | 6.48 |
| Payables Turnover | 8.79 | 7.06 | 7.42 | 7.18 | 7.63 |
| Inventory Turnover | 64.52 | 71.52 | 69.53 | 45.24 | 36.89 |
| Fixed Asset Turnover | 1.39 | 1.28 | 1.24 | 1.13 | 1.08 |
| Asset Turnover | 0.76 | 0.69 | 0.90 | 0.81 | 0.78 |
| Working Capital Turnover Ratio | 4.52 | 5.89 | -43.94 | -31.65 | -54.04 |
| Cash Conversion Cycle | 6.47 | -7.15 | -1.80 | 7.54 | 18.39 |
| Days of Sales Outstanding | 42.32 | 39.47 | 42.16 | 50.33 | 56.36 |
| Days of Inventory Outstanding | 5.66 | 5.10 | 5.25 | 8.07 | 9.89 |
| Days of Payables Outstanding | 41.51 | 51.72 | 49.21 | 50.86 | 47.87 |
| Operating Cycle | 47.98 | 44.58 | 47.41 | 58.39 | 66.25 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 8.68 | 9.36 | 8.02 | 8.45 | 3.90 |
| Free Cash Flow Per Share | 2.04 | 3.37 | 2.67 | -2.53 | -4.33 |
| Dividend Paid and CapEx Coverage Ratio | 1.23 | 1.47 | 1.38 | 0.77 | 0.47 |
| Capital Expenditure Coverage Ratio | 1.31 | 1.56 | 1.50 | 0.77 | 0.47 |
| Operating Cash Flow Coverage Ratio | 0.52 | 0.50 | 0.34 | 0.39 | 0.26 |
| Operating Cash Flow to Sales Ratio | 0.13 | 0.16 | 0.12 | 0.15 | 0.09 |
| Free Cash Flow Yield | 0.99% | 1.24% | 1.53% | -3.73% | -9.43% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 31.33 | 50.58 | 48.23 | 23.46 | 19.10 |
| Price-to-Sales (P/S) Ratio | 3.00 | 4.51 | 2.70 | 1.23 | 1.10 |
| Price-to-Book (P/B) Ratio | 3.47 | 5.05 | 5.29 | 2.25 | 1.69 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 100.85 | 80.55 | 65.28 | -26.82 | -10.60 |
| Price-to-Operating Cash Flow Ratio | 23.67 | 29.02 | 21.77 | 8.03 | 11.78 |
| Price-to-Earnings Growth (PEG) Ratio | 1.41 | 1.05 | 1.91 | 1.15 | 0.05 |
| Enterprise Value Multiple | 17.55 | 27.15 | 21.47 | 11.54 | 11.12 |
| Enterprise Value | 33.02B | 41.21B | 26.76B | 11.69B | 7.93B |
| EV to EBITDA | 17.55 | 27.15 | 21.47 | 11.54 | 11.12 |
| EV to Sales | 3.05 | 4.40 | 3.05 | 1.59 | 1.43 |
| EV to Free Cash Flow | 102.57 | 78.55 | 73.70 | -34.60 | -13.84 |
| EV to Operating Cash Flow | 24.08 | 28.30 | 24.58 | 10.37 | 15.38 |
| Tangible Book Value Per Share | 56.14 | 50.89 | 29.91 | 26.89 | 23.82 |
| Shareholders’ Equity Per Share | 59.18 | 53.83 | 33.02 | 30.23 | 27.15 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.25 | 0.24 | 0.28 | 0.25 | 0.16 |
| Revenue Per Share | 68.45 | 60.21 | 64.71 | 55.23 | 41.76 |
| Net Income Per Share | 6.56 | 5.31 | 3.62 | 2.89 | 2.40 |
| Tax Burden | 0.74 | 0.77 | 0.72 | 0.76 | 0.86 |
| Interest Burden | 0.99 | 1.01 | 0.73 | 0.72 | 0.76 |
| Research & Development to Revenue | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| SG&A to Revenue | 0.07 | 0.01 | 0.00 | 0.00 | 0.01 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Income Quality | 1.32 | 1.76 | 2.22 | 2.92 | 1.62 |
Currency in INR

